Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Tesaro, Inc.
Toray Industries, Inc
M.D. Anderson Cancer Center
Shanghai Junshi Bioscience Co., Ltd.
DEKA Biosciences
Eli Lilly and Company
Cantargia AB
City of Hope Medical Center
Children's Oncology Group
National Cancer Institute (NCI)
Fox Chase Cancer Center
Mayo Clinic